bioAffinity Technologies Announces Poster Presentation at CYTO 2020 Conference

SAN ANTONIO--(BUSINESS WIRE)-- #BioTech--bioAffinity Technologies, a privately held biotech company, today presented a poster explaining the Company’s use of flow cytometry for diagnosis of lung disease, including cancer, at the International Society for Advancement of Cytometry CYTO 2020. The CYTO 2020 conference runs today and tomorrow in a virtual format due to COVID-19. “We are pleased to have the opportunity to share our cutting-edge use of flow cytometry for accurate, non-invasive lung cancer diagno